CAS No.:7421-40-1
Name: Carbenoxolone disodium
Details Introduction
TOXICITY DATA with REFERENCEļ¼
|
1. |
|
orl-hmn TDLo:120 mg/kg/6 W:CVS,MET |
CMAJAX Canadian Medical Association Journal. 117 (1977),1155. | |
| 2. |
orl-rat LD50:2450 mg/kg |
OYYAA2 Oyo Yakuri. Pharmacometrics. 11 (1976),263. | ||
| 3. |
ipr-rat LD50:112 mg/kg |
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. 10 (1979),710. | ||
| 4. |
scu-rat LD50:1515 mg/kg |
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. 10 (1979),710. | ||
| 5. |
ipr-mus LD50:120 mg/kg |
21NDAB Symposium on Carbenoxolone Sodium Robson, J.M., andF.M. Sullivan, eds.,London, UK.: Butterworth,1968,6. | ||
| 6. |
ivn-mus LD50:198 mg/kg |
21NDAB Symposium on Carbenoxolone Sodium Robson, J.M., andF.M. Sullivan, eds.,London, UK.: Butterworth,1968,6. | ||
| 7. |
orl-dog LD50:3900 mg/kg |
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. 10 (1979),710. | ||
| 8. |
ipr-dog LD50:371 mg/kg |
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. 10 (1979),710. | ||
| 9. |
scu-dog LD50:1060 mg/kg |
OYYAA2 Oyo Yakuri. Pharmacometrics. 11 (1976),263. | ||
| 10. |
ivn-dog LD50:371 mg/kg |
|
OYYAA2 O CARBENOXALONE, DISODIUM SALT (7421-40-1) has toxicity. Organism Test Type Route Reported Dose (Normalized Dose) Effect Source CARDIAC: PULSE RATE Oyo Yakuri. Pharmacometrics. Vol. 11, Pg. 263, 1976. BEHAVIORAL: TREMOR Oyo Yakuri. Pharmacometrics. Vol. 11, Pg. 263, 1976. LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION SKIN AND APPENDAGES (SKIN): HAIR: OTHER Oyo Yakuri. Pharmacometrics. Vol. 11, Pg. 263, 1976.
|
SAFETY PROFILEļ¼
Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion and subcutaneous routes. Human systemic effects by ingestion: blood pressure increase, change in blood potassium levels. Experimental reproductive effects. An anti-inflammatory agent used to treat gastric ulcers. When heated to decomposition CARBENOXALONE, DISODIUM SALT (7421-40-1) emits toxic fumes of Na2O.
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione


